Reuteri Probiotic chewable tablet
Baby and child gut health
Reuteri probiotic chewable tablets is a food supplement containing the patented lactic acid bacterium Limosilactobacillus reuteri (formerly known as Lactobacillus reuteri) Protectis (L. reuteri DSM 17938) that helps the good microorganisms restore a natural balance in the gut.
- 1 tablet per day
- >One tablet consists of a minimum of 100 million live L. reuteri Protectis
- Tested in more than 150 clinical trials
- Strong adaptation to persist and interact with humans
Storage: Store in a dry place, not above room temperature (max 25 °C/77 °F). Keep out of reach of children.
Bulking agent (isomalt), sweetener (xylitol), L. reuteri DSM 17938, palm oil, strawberry flavoring and flavor enhancer (citric acid). One tablet consists of a minimum of 100 million live L. reuteri Protectis. Net weight per tablet, 450 mg. Excessive consumption may have a laxative effect due to the content of sweeteners in the product.
1–2 chewable tablets per day. Use regularly for good gut health or when temporary stomach dis comfort occurs. Recommended daily dose should not be exceeded. This product should not be used as a substitute for a varied diet.
What is the difference between Protectis, Gastrus, Prodentis and Osfortis?
The main difference between Protectis, Gastrus, Prodentis and Osfortis is that they contain different probiotic L. reuteri strains, or combinations of L. reuteri probiotic strains.
Protectis contains L. reuteri DSM 17938
Osfortis contains L. reuteri ATCC PTA 6475
Gastrus contains L. reuteri DSM 17938 and L. reuteri ATCC PTA 6475
Prodentis contains L. reuteri DSM 17938 and L. reuteri ATCC PTA 5289
All BioGaia’s probiotic products have been tested in clinical studies and found safe and effective.
All BioGaia’s probiotic L. reuteri strains have been shown to survive in the human gastrointestinal tract and to temporarily colonise the small intestine. They have also been shown to have a positive effect on the microbiota composition.
Are there any side effects from taking BioGaia probiotics (Protectis/Gastrus/Prodentis)?
BioGaia probiotics very rarely cause side effects in the amounts recommended for the products. Since every gastrointestinal tract is unique some individuals might experience a temporary change in gut motility or excessive gas, when starting on a true probiotic, but that generally disappears after a few days. No serious adverse effects have been observed in clinical trials up to the maximum tested dosage of 10 billion CFU per day.
Can BioGaia’s products be stored in room temperature?
BioGaia products comes in different versions, we therefore recommend you to follow the instructions on the package. However, if room temperature is above 25°C/77°F we always recommend storage in the fridge.
Can BioGaia Protectis drops be stored in the freezer?
BioGaia Protectis baby drops should not be stored in the freezer, as this will significantly shorten the shelf-life of the product.
How should BioGaia Protectis drops be stored?
BioGaia Protectis drops comes in two different versions, we therefore recommend you to follow the instructions on the package. However, if room temperature is above 25°C/77°F we always recommend storage in the fridge.
Why does BioGaia Protectis drops come in a new delivery system?
In BioGaia we are constantly working on improving our products. The Easydropper is a new delivery system for probiotic products. It has an improved drop function which facilitates the administration of the product and less environmental impact compared to glass bottles.
What are the brownish dots that sometimes appear on the surface of BioGaia Protectis tablets?
The spots are not dangerous and the product can still be used. BioGaia Protectis tablets contains ascorbic acid, which is an antioxidant that contributes to the stability of the tablets. Over time the ascorbic acid oxidizes and the color becomes darker. This darkening is seen as small “spots” on the tablet.
Are multi-strain products better than single-strain probiotic products?
Multi-strain products containing several strains in high doses do not necessarily have a better effect than a single-strain product. Important criteria when choosing a probiotic product are:
• The probiotic bacteria must be defined on strain level
• The probiotic product must have been tested in human clinical studies, with the same dose and with the same bacterial strain(s) as in the commercial product.
What is Limosilactobacillus reuteri?
Limosilactobacillus reuteri, formerly known as Lactobacillus reuteri and often written L. reuteri, is a probiotic bacterium that has co-evolved with humans since the beginning of time, and because of that it is adapted to its host. L. reuteri is one of the first bacterial species to naturally become established in the microbiota of a newborn baby. BioGaia’s probiotic products with L. reuteri are among the most scientifically well-documented probiotics in the world in terms of both efficacy and safety. To date, over 258 clinical studies with BioGaia’s L. reuteri-strains have been performed in approximately 21,000 people of all ages. Positive results have been shown for several gastrointestinal disorders, oral health, and bone health.
Read more about L. reuteri.
What company has the distribution rights for BioGaia’s products where I live?
Please go to Distribution network or Our products for more information.